Position in VTRS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$115,445,597
+$7,607,059 QoQ
Shares Held
8,545,196
-1.3% QoQ
Ownership
0.734%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 84.9875649429223.ToString("F0")%
Shared 0.ToString("F0")%
None 15.012435057077683.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $805,226,112 across 23 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,975,559 | $233,530,829 | |
| 2 | HLN |
Haleon plc
|
14,674,518 | $146,891,925 | |
| 3 | VTRS |
Viatris Inc
This page
|
8,545,196 | $115,445,597 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,323,264 | $70,813,086 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,116,311 | $57,714,079 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
564,360 | $43,399,284 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
892,666 | $42,981,867 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
703,528 | $23,265,670 |
All Filings in VTRS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $115,445,597 | 8,545,196 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $107,838,538 | 8,661,730 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $87,638,948 | 8,852,419 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $67,228,129 | 7,528,346 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $5,778,283 | 663,408 | Shares | Defined | 2025-05-14 | |
| 2024-09-30 | $29,829,178 | 2,569,266 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,672,371 | 1,003,986 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $19,216,383 | 1,774,366 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $97,386,766 | 9,876,954 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $117,914,887 | 11,815,119 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $140,918,002 | 14,648,441 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $209,315,476 | 18,806,422 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $151,231,252 | 17,750,147 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $130,597,482 | 12,473,494 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $36,323,565 | 3,338,563 | Shares | Defined | 2022-05-13 | |
| 2021-09-30 | $5,615,120 | 414,400 | Shares | Defined | 2021-11-12 | |
| 2021-03-31 | $52,491,632 | 3,757,454 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $88,633,434 | 4,729,639 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||